For Immediate Release
Chicago, IL – February 24, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Apple Inc. (
AAPL Quick Quote AAPL - Free Report) , AGCO Corporation ( AGCO Quick Quote AGCO - Free Report) , Boot Barn Holdings, Inc. ( BOOT Quick Quote BOOT - Free Report) , Beazer Homes USA, Inc. ( BZH Quick Quote BZH - Free Report) and Knowles Corporation ( KN Quick Quote KN - Free Report) . Here are highlights from Tuesday’s Analyst Blog: 5 Top Growth Stocks to Buy for a Post COVID-19 Economic Boom
The coronavirus outbreak disrupted economic growth in the United States for most part of last year, squeezing corporate profits and bankrupting several organizations. But things are certainly looking up this year, thanks to the breakthrough in the coronavirus vaccine front in the latter half of 2020. Most importantly, the rollout of the much-anticipated vaccine has now gathered steam, while the rise in coronavirus cases is certainly ebbing.
Needless to say, trillions of dollars in federal aid perk up the economy, which many had feared to have been headed for recession last spring. In fact, President Biden is widely expected to implement as early as possible the promised $1.9-trillion stimulus package to jump-start the economy. The aid is aimed at improving the finances of households and will also benefit small business organizations that were pretty badly bruised by the pandemic.
Meanwhile, households have saved up a lot mostly due to the lockdown-led savings made last year and an array of stimulus payments. Now, with the economy gradually reopening, consumers are certainly expected to splurge, thereby boosting economic growth.
By the way, there are signs of rising spending by consumers and the economy has turned a corner. After all, sales at U.S. retailers improved in January for the first time since September. According to the Commerce Department, retail sales jumped 5.3% after a drop of 1% in December, as mentioned in a
Notably, the latest $600 stimulus checks improved outlays across all major retail categories. What's more, consumers are expected to spend more in the days ahead and perk up the economy since the Biden administration is likely to provide $1400 stimulus checks predominantly to lower-income workers (read more:
2021 Has Been Good to Retail So Far: 5 Top Picks).
But skeptics continue to remain pessimistic due to the sluggish jobs market. However, both the manufacturing and service side of the economy have shown considerable improvement so far this year, a tell-tale sign that job additions will eventually improve and drive wages. The gradual reopening of businesses and solid consumer demand for factory products provided strength to the manufacturing sector last month (read more:
US Manufacturing Remains a Bright Side in Early 2021: 5 Picks).
Similarly, the beleaguered service sector has now started to return back to normal, with demand for new orders picking up and service providers continuing to demonstrate an adequate amount of confidence about the future business outlook (read more:
Things Perk Up for Service Side of the US Economy: 5 Picks).
Notably, the Congressional Budget Office (CBO) now expects the U.S. economy to grow much faster, with GDP returning back to pre-pandemic levels by the middle of this year. Congressional aid for both households and businesses is expected to boost the economy. The CBO said that the U.S. economy will expand "rapidly" in the near term and real GDP will grow 3.7% in 2021, as quoted from a
Thus, from an investment standpoint, the stock market's performance is directly related to economic growth. And with the economic growth expected to only improve from here, stocks are poised to climb as well. We have, thus, selected five solid growth stocks that should make meaningful additions for your portfolio now. These stocks flaunts a Zacks Rank #1 (Strong Buy) or 2 (Buy) and a
Growth Score of A or B. Apple designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories. The company currently has a Zacks Rank #1 and a Growth Score of A. The Zacks Consensus Estimate for its current-year earnings has moved 10.9% north over the past 60 days. The company's expected earnings growth rate for the current year is 36.3%. AGCO Corp. is a leading manufacturer and distributor of agricultural equipment and related replacement parts. The company currently has a Zacks Rank #2 and a Growth Score of A. The Zacks Consensus Estimate for its current-year earnings has climbed 18.3% over the past 60 days. The company's expected earnings growth rate for the current year is almost 30%. Boot Barn Holdings operates as a lifestyle retail chain devoted to western and work-related footwear, apparel and accessories. The company currently has a Zacks Rank #1 and a Growth Score of A. The Zacks Consensus Estimate for its current-year earnings has advanced 21.2% over the past 60 days. The company's expected earnings growth rate for the current-quarter is 133.3%.You can see the complete list of today's Zacks #1 Rank stocks here . Beazer Homes designs, builds and sells single family homes. The company currently has a Zacks Rank #2 and a Growth Score of B. The Zacks Consensus Estimate for its current-year earnings has risen almost 14% over the past 60 days. The company's expected earnings growth rate for the current year is 16.4%. Knowles Corp. is a premier provider of advanced micro-acoustic, audio processing and precision device solutions, serving the mobile consumer electronics, communications, medical, defense, automotive and industrial markets. The company currently has a Zacks Rank #1 and a Growth Score of A. The Zacks Consensus Estimate for its current-year earnings has moved up 5.9% over the past 60 days. The company's expected earnings growth rate for the current year is 88.1%. Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They're also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released
Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better. See these 7 breakthrough stocks now>>
Zacks Investment Research
800-767-3771 ext. 9339
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss
. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.